The effects of histone deacetylase inhibitor and calpain inhibitor combination therapies on ovarian cancer cells
K Lapinska, G Housman, S Byler, S Heerboth… - Anticancer …, 2016 - ar.iiarjournals.org
Background: Ovarian cancer is difficult to treat due to absence of selective drugs and
tendency of platinum drugs to promote resistance. Combination therapy using epigenetic …
tendency of platinum drugs to promote resistance. Combination therapy using epigenetic …